Title : Suppression of Wnt/β-catenin and RAS/ERK pathways provides a therapeutic strategy for gemcitabine-resistant pancreatic cancer.

Pub. Date : 2021 Apr 16

PMID : 33662667






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 However, patients often develop resistance to gemcitabine that is attributed to KRAS mutations. gemcitabine KRAS proto-oncogene, GTPase Homo sapiens